Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted naphthalimides such as amonafide for the treatment of immunological, metabolic, infectious, and benign or neoplastic hyperproliferative disease conditions
WO2014168986A1
Therapeutic benefit of suboptimally administered chemical compounds
US2011312034A1
Recombined molecules and preparation thereof
US2011049741A1
Method of making ceramic bodies having reduced shape variability
WO2004099839A2
A spool with substantially temperature insensitive hub and a method of making same
WO0178705A2
Compositions containing a naphthalmide and an antiproliferative agent
WO0180842A2
Compositions comprising a methylnogarol in combination with an antiproliferative agent
